@article{SchmidtFantuzziKlopfetal.2021, author = {Schmidt, Paul and Fantuzzi, Felipe and Klopf, Jonas and Schr{\"o}der, Niklas B. and Dewhurst, Rian D. and Braunschweig, Holger and Engel, Volker and Engels, Bernd}, title = {Twisting versus delocalization in CAAC- and NHC-stabilized boron-based biradicals: the roles of sterics and electronics}, series = {Chemistry - A European Journal}, volume = {27}, journal = {Chemistry - A European Journal}, number = {16}, doi = {10.1002/chem.202004619}, url = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-256636}, pages = {5160-5170}, year = {2021}, abstract = {Twisted boron-based biradicals featuring unsaturated C\(_2\)R\(_2\) (R=Et, Me) bridges and stabilization by cyclic (alkyl)(amino)carbenes (CAACs) were recently prepared. These species show remarkable geometrical and electronic differences with respect to their unbridged counterparts. Herein, a thorough computational investigation on the origin of their distinct electrostructural properties is performed. It is shown that steric effects are mostly responsible for the preference for twisted over planar structures. The ground-state multiplicity of the twisted structure is modulated by the σ framework of the bridge, and different R groups lead to distinct multiplicities. In line with the experimental data, a planar structure driven by delocalization effects is observed as global minimum for R=H. The synthetic elusiveness of C\(_2\)R\(_2\)-bridged systems featuring N-heterocyclic carbenes (NHCs) was also investigated. These results could contribute to the engineering of novel main group biradicals.}, language = {en} } @article{WohlfartHolzgrabe2021, author = {Wohlfart, Jonas and Holzgrabe, Ulrike}, title = {Analysis of histamine and sisomicin in gentamicin: search for the causative agents of adverse effects}, series = {Archiv der Pharmazie}, volume = {354}, journal = {Archiv der Pharmazie}, number = {12}, doi = {10.1002/ardp.202100260}, url = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-256596}, year = {2021}, abstract = {In 1998, the aminoglycoside antibiotic gentamicin sulfate caused several cases of deaths in the United States, after the switch from twice- to once-daily application. Endotoxins were discussed as the cause for the adverse effects and sisomicin was identified as the lead impurity; batches containing sisomicin were contaminated with more impurities and were responsible for the fatalities. In 2016, anaphylactic reactions in horses, and later in humans with one fatality, were observed after application of gentamicin sulfate contaminated with histamine. To determine whether histamine was responsible for the 1990s death cases as well, histamine was quantified by means of liquid chromatography-tandem mass spectrometry (LC-MS/MS) in 30 samples of gentamicin sulfate analyzed in previous studies. Furthermore, a relative quantification of sisomicin was performed to check for a correlation between histamine and the lead impurity. A maximum amount of 11.52 ppm histamine was detected, which is below the limit for anaphylactic reactions of 16 ppm, and no correlation of the two impurities was observed. However, the European Medicines Agency recommends a stricter limit with regard to the maximum single dose of gentamicin sulfate to reach a greater gap between the maximum histamine exposition of 4.3 µg and the quantity known to cause hypotension of 7 µg. The low amounts of histamine and the fact that there is no connection with the contamination with sisomicin showed that histamine was not the cause for the death cases in the United States in 1998, and endotoxins remain the most probable explanation.}, language = {en} }